Flanvotumab Biosimilar(Anti-TRP1 / TYRP1 Reference Antibody) Datasheet DC Chemicals
Description Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance.
Cat.No A621
Name Flanvotumab Biosimilar(Anti-TRP1 / TYRP1 Reference Antibody)

Chemical Properties

CAS 1188277-05-5
Synonyms Flanvotumab;Research Grade Flanvotumab (DHD25201);Research Grade Flanvotumab (DHD25201);Research Grade Flanvotumab (DHD25201);Research Grade Flanvotumab (DHD25201);Research Grade Flanvotumab (DHD25201);Flanvotumab (anti-TYRP1);Flanvotumab (anti-TYRP1);Flanvotumab (anti-TYRP1);Flanvotumab (anti-TYRP1);Flanvotumab (anti-TYRP1);20D7S|||IMC 20D7S;20D7S|||IMC 20D7S;20D7S|||IMC 20D7S;20D7S|||IMC 20D7S;20D7S|||IMC 20D7S
pH value Corresponds to reference standard: PASS
Non-reduced CE-SDS >95%
SEC-HPLC >95%
Isoelectric Point Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality Corresponds to reference standard: PASS
Peptide mapping Corresponds to reference standard: PASS
N-terminal sequence Corresponds to reference standard: PASS

References

Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com